ClariTrial | Search Clinical Trials

Ixazomib, thalidomide, & dexamethasone (ITD) re-inductionConventional autologous stem cell transplant (ASCT-con)Augmented autologous stem cell transplant (ASCT-aug)+1 more

University of Leeds406 participants91 sites · United KingdomCompletes Mar 2026

Compare CT.gov Full analysis →

Recruiting

Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis

Phase 2Infective Endocarditis

68Ga-citrate PET/CT

University Hospital, Bordeaux40 participants1 site · FranceCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Phase 1Phase 2Relapsed/Refractory Systemic Light Chain Amyloidosis

Linvoseltamab

Regeneron Pharmaceuticals220 participants21 sites · United States, Greece, South KoreaCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

Serotonin Receptor Blockers in Ischemic Mitral Regurgitation

Phase 2Ischemic Mitral Regurgitation

Cyproheptadine 4 Mg Oral TabletPlacebo

Laval University214 participants1 site · CanadaCompletes Sep 2026

Compare CT.gov Full analysis →

1–15 of 586

Explore/cardiovascular heart disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

586 results for “cardiovascular heart disease” · Recruiting · Phase 3 · Phase 2

Page 1 of 40

Recruiting

Normobaric Oxygen in AIS Transferred for EVT

Phase 3Ischemic Stroke

NBOControl

Capital Medical University1,500 participants112 sites · ChinaCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis

Phase 3Aortic Stenosis

PCSK9 inhibitors and statins with or without ezetimibeStatins with or without ezetimibe

Beijing Anzhen Hospital160 participants1 site · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis

Phase 2Juvenile Idiopathic Arthritis

OKZ q4wOKZ q4w

R-Pharm International, LLC71 participants14 sites · RussiaCompletes Sep 2026

Compare CT.gov Full analysis →

Recruiting

The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease

Phase 2Acute Kidney Injury

dapagliflozinOther anti-diabetic drug or no anti-diabetic drugempagliflozin+1 more

National Taiwan University Hospital264 participants1 site · TaiwanCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease

Phase 3Hypertension (HTN)

Combination Product: FDC of spironolactone and ER torsemideCombination Product: Stabilized doses of loop diuretic and finerenone

Sarfez Pharmaceuticals, Inc.30 participants1 site · United StatesCompletes Jul 2026

Compare CT.gov Full analysis →

Recruiting

Inhaled DMT for Major Depressive Disorder

Phase 2MDDMajor Depressive Disorder (MDD)Major Depression

N,N-Dimethyltryptamine (15 mg + 60 mg)N,N-Dimethyltryptamine (1 mg + 4 mg)

Universidade Federal do Rio Grande do Norte140 participants5 sites · BrazilCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome

Phase 3Postresuscitation Syndrome

Administration of AVPAdministration of placebo AVPAdministration of placebo hydrocortisone+1 more

Assistance Publique - Hôpitaux de Paris380 participants14 sites · FranceCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution and NUMBRINO™ Nasal Solution

Phase 3ENT DisorderNasal ProceduresNasal Anesthesia

Cocaine Hydrochloride Nasal SolutionCocaine Hydrochloride Nasal Solution

Noden Pharma40 participants4 sites · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Phase 3Breast Cancer FemaleEstrogen Receptor Positive Tumor

Atorvastatin 80 Mg Oral TabletPlacebo oral tablet

Aarhus University Hospital3,360 participants1 site · DenmarkCompletes Jan 2025

Compare CT.gov Full analysis →

Recruiting

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Phase 3Familial Hypercholesterolemia - Homozygous

InclisiranPlacebo

Novartis Pharmaceuticals9 participants19 sites · United States, Austria, ChinaCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Phase 3Community-acquired Pneumonia, Influenza, COVID-19

CeftriaxoneMoxifloxacin or LevofloxacinPiperacillin-tazobactam+59 more

UMC Utrecht20,000 participants408 sites · United States, Australia, BelgiumCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

Phase 3Multiple Myeloma

Ixazomib, thalidomide, & dexamethasone (ITD) re-inductionConventional autologous stem cell transplant (ASCT-con)Augmented autologous stem cell transplant (ASCT-aug)+1 more